Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8+ Fas (CD95)+ T lymphocytes

被引:94
|
作者
Puppo, F
Contini, P
Ghio, M
Brenci, S
Scudeletti, M
Filaci, G
Ferrone, S
Indiveri, F
机构
[1] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy
[2] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
HLA; immunomodulation;
D O I
10.1093/intimm/12.2.195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the present study, we have evaluated the apoptotic effect of soluble human MHC class I (sHLA-I) antigens on CD8(+) T lymphocytes. sHLA-I antigens and beta(2)-microglobulin-free HLA class I heavy chains, isolated from serum, induced apoptosis on phytohemagglutinin-activated CD8(+) T lymphocytes in autologous and allogeneic combinations. The extent of CD8(+) T cell apoptosis depends on the degree of activation, time of incubation with sHLA-I antigens and amount of sHLA-I antigens added to the cultures. Apoptosis is induced by the interaction of Fas (CD95)(+) cells with soluble Fas ligand which is released following binding of sHLA-I antigens to CD8 molecules. These results suggest that sHLA-I antigens may regulate immune responses by inducing apoptosis in activated CD8(+) T cells.
引用
收藏
页码:195 / 203
页数:9
相关论文
共 50 条
  • [1] Soluble HLA class I molecules induce apoptosis in human PHA-activated CD8+ T lymphocytes
    Puppo, F
    Contini, P
    Ghio, M
    Brenci, S
    Bosco, O
    Lanza, L
    Scudeletti, M
    Indiveri, F
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P819 - P819
  • [2] Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases
    Nozawa, K
    Kayagaki, N
    Tokano, Y
    Yagita, H
    Okumura, K
    Hasimoto, H
    ARTHRITIS AND RHEUMATISM, 1997, 40 (06): : 1126 - 1129
  • [3] Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8+ cytotoxic T lymphocytes by Fas/Fas-ligand interaction
    Contini, P
    Ghio, M
    Merlo, A
    Brenci, S
    Filaci, G
    Indiveri, F
    Puppo, F
    HUMAN IMMUNOLOGY, 2000, 61 (12) : 1347 - 1351
  • [4] Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure
    Perianayagam, MC
    Murray, SL
    Balakrishnan, VS
    Guo, DQ
    King, AJ
    Pereira, BJG
    Jaber, BL
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 136 (04): : 320 - 327
  • [5] Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura
    Yoshimura, C
    Nomura, S
    Nagahama, M
    Ozaki, Y
    Kagawa, H
    Fukuhara, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 64 (04) : 219 - 224
  • [6] Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8
    Fournel, S
    Aguerre-Girr, M
    Huc, X
    Lenfant, F
    Alam, A
    Toubert, A
    Bensussan, A
    Le Bouteiller, P
    JOURNAL OF IMMUNOLOGY, 2000, 164 (12): : 6100 - 6104
  • [7] In vivo apoptosis of CD8+ lymphocytes in acute myeloid leukemia patients:: involvement of soluble HLA-I and Fas ligand
    Contini, P.
    Zocchi, M. R.
    Pierri, I.
    Albarello, A.
    Poggi, A.
    LEUKEMIA, 2007, 21 (02) : 253 - 260
  • [8] Soluble Fas (CD95/Apo-1), Soluble Fas Ligand, and Activated Caspase 3 in the Cerebrospinal Fluid of Infants with Posthemorrhagic and Nonhemorrhagic Hydrocephalus
    Ursula Felderhoff-Mueser
    Christoph Bührer
    Peter Groneck
    Michael Obladen
    Peter Bartmann
    Axel Heep
    Pediatric Research, 2003, 54 : 659 - 664
  • [9] In vivo apoptosis of CD8+ lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand
    P Contini
    M R Zocchi
    I Pierri
    A Albarello
    A Poggi
    Leukemia, 2007, 21 : 253 - 260
  • [10] Soluble Fas (CD95/Apo-1), soluble Fas ligand, and activated caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and nonhemorrhagic hydrocephalus
    Felderhoff-Mueser, U
    Bührer, C
    Groneck, P
    Obladen, M
    Bartmann, P
    Heep, A
    PEDIATRIC RESEARCH, 2003, 54 (05) : 659 - 664